We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+34.79%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$22.9M
(+18%)
Cap. Flow
-$5.55M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
33.53%
Holding
141
New
14
Increased
30
Reduced
63
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veritone
VERI
|
+$1.36M |
| 2 |
TEUM
Pareteum Corporation
TEUM
|
+$1.26M |
| 3 |
Natera
NTRA
|
+$1.12M |
| 4 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
+$983K |
| 5 |
AbbVie
ABBV
|
+$879K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$2.81M |
| 2 |
CareDx
CDNA
|
+$1.92M |
| 3 |
Apyx Medical
APYX
|
+$1.7M |
| 4 |
Vericel Corp
VCEL
|
+$1.1M |
| 5 |
Intel
INTC
|
+$976K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.79% |
| 2 | Technology | 15.22% |
| 3 | Industrials | 5.82% |
| 4 | Communication Services | 5.78% |
| 5 | Consumer Discretionary | 2.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVGR
26
DELISTED
Avinger, Inc. Common Stock
AVGR
| $1.64M | 1.08% |
571
-12
| -2% | -$18.6K |
|
27
AT&T
T
$159B
| $1.61M | 1.06% |
67,970
+23,799
| +54% | +$547K |
|
|
HTGM
28
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $1.55M | 1.02% |
3,444
+944
| +38% | +$413K |
|
|
29
Apyx Medical
APYX
$173M
| $1.55M | 1.02% |
245,540
-220,160
| -47% | -$1.7M |
|
30
Aflac
AFL
$64.9B
| $1.54M | 1.02% |
30,850
-4,000
| -11% | -$193K |
|
|
IDXG
31
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $1.54M | 1.01% |
192,225
+89,125
| +86% | +$838K |
|
|
CEMI
32
DELISTED
Chembio diagnostics, Inc.
CEMI
| $1.51M | 1% |
272,650
+151,250
| +125% | +$983K |
|
|
TTSH
33
DELISTED
Tile Shop Holdings
TTSH
| $1.49M | 0.98% |
263,600
-22,000
| -8% | -$143K |
|
|
ATRS
34
DELISTED
Antares Pharma, Inc.
ATRS
| $1.34M | 0.88% |
441,000
+32,000
| +8% | +$104K |
|
|
35
Veritone
VERI
$101M
| $1.27M | 0.84% |
+245,000
| New | +$1.36M |
|
36
Target
TGT
$65.6B
| $1.26M | 0.83% |
15,700
-2,750
| -15% | -$201K |
|
|
CGRN
37
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $1.24M | 0.81% |
137,490
+6,376
| +5% | +$54.9K |
|
|
CYBE
38
DELISTED
Cyberoptics Corp
CYBE
| $1.23M | 0.81% |
72,000
-9,750
| -12% | -$193K |
|
39
Airgain
AIRG
$73.4M
| $1.2M | 0.79% |
93,800
+1,250
| +1% | +$14.7K |
|
|
CTLP
40
DELISTED
Cantaloupe
CTLP
| $1.2M | 0.79% |
287,935
+175,900
| +157% | +$788K |
|
41
LifeVantage
LFVN
$81.1M
| $1.17M | 0.77% |
81,925
| – | – |
|
42
Boston Scientific
BSX
$69.5B
| $1.15M | 0.75% |
29,850
-5,000
| -14% | -$191K |
|
43
Microvision
MVIS
$6.21M
| $1.09M | 0.72% |
1,126,500
-65,500
| -5% | -$63.3K |
|
44
BioLife Solutions
BLFS
$1.53B
| $1.09M | 0.72% |
60,750
+10,000
| +20% | +$159K |
|
45
AngioDynamics
ANGO
$611M
| $1.05M | 0.69% |
45,750
+7,300
| +19% | +$158K |
|
46
Ciena
CIEN
$53.4B
| $1.04M | 0.68% |
27,750
-2,500
| -8% | -$97.1K |
|
47
Verizon
VZ
$195B
| $999K | 0.66% |
16,900
-3,250
| -16% | -$184K |
|
48
The Joint Corp
JYNT
$118M
| $986K | 0.65% |
62,600
-3,900
| -6% | -$41.3K |
|
|
NVTA
49
DELISTED
Invitae Corporation
NVTA
| $939K | 0.62% |
+40,100
| New | +$707K |
|
|
BEAT
50
DELISTED
BioTelemetry, Inc.
BEAT
| $939K | 0.62% |
15,000
| – | – |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Perkins Capital Management held 141 positions worth $152M, up 18% from $129M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Perkins Capital Management withdrew a net $5.55M in Q1 2019, closing 17 positions and reducing 63 holdings. Its most notable exit was Intel, an estimated $976K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 63% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in Veritone worth $1.27M.
- Perkins Capital Management's largest Q1 2019 buy was Veritone: 245,000 shares worth $1.27M.
- Perkins Capital Management added most to Pareteum Corporation in Q1 2019, an estimated $1.26M increase.
- Perkins Capital Management's biggest Q1 2019 reduction was Abbott, cutting an estimated $2.81M.
- Perkins Capital Management fully exited Intel in Q1 2019, selling an estimated $976K.
- Perkins Capital Management's ten largest holdings make up 34% of its $152M portfolio in Q1 2019.
- Perkins Capital Management opened 14 new positions and closed 17 in Q1 2019.
- Perkins Capital Management's portfolio value rose 18% quarter-over-quarter to $152M.
Based on Perkins Capital Management's 13F filing for Q1 2019, filed 22 Apr 2019.